Format

Send to

Choose Destination
FEMS Microbiol Lett. 2016 Oct;363(19). pii: fnw212. Epub 2016 Sep 11.

Escherichia coli strain Nissle 1917-from bench to bedside and back: history of a special Escherichia coli strain with probiotic properties.

Author information

1
Biological Research Division, Ardeypharm GmbH, 58313 Herdecke, Germany ulrich.sonnenborn@gmx.de.

Abstract

Among the gram-negative microorganisms with probiotic properties, Escherichia coli strain Nissle 1917 (briefly EcN) is probably the most intensively investigated bacterial strain today. Since nearly 100 years, the EcN strain is used as the active pharmaceutical ingredient in a licensed medicinal product that is distributed in Germany and several other countries. Over the last few decades, novel probiotic activities have been detected, which taken together are specific of this versatile E. coli strain. This review gives a short overview on the discovery and history of the EcN strain.

KEYWORDS:

E. coli Nissle 1917; Escherichia coli; discovery; history; probiotic

PMID:
27619890
DOI:
10.1093/femsle/fnw212
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center